The Stony Brook University School of Dental Medicine is leading a multicenter National Institutes of Health-sponsored clinical trial to evaluate whether treatment of chronic periodontitis will help improve diabetes control.
Dental School.s Gary Hack, DDS, co-inventor of NovaMin, is elated that giant pharma and dental product firms are putting desensitizing dental additive into mass-marketed products.
The vegetables most boys wanted to avoid in childhood – such as kale and broccoli – just may be the answer to staving off prostate cancer growth in adulthood. A new clinical trial at UC San Diego Moores Cancer Center will evaluate whether or not a change in diet, reinforced with telephone counseling and exercise, can stop or delay the progression of prostate cancer.
Young NASCAR fans at the March 12 SpeedFest will learn how to improve their oral health and score free oral health kits. On October 15, volunteer dentists will give underserved children free dental evaluations, fluoride treatments and dental sealants at the Charlotte Motor Speedway’s Kid Zone.
The Roger C. Lipitz Center for Integrated Health Care at the Johns Hopkins Bloomberg School of Public Health is offering free technical assistance to help primary care practices and health care organizations, including accountable care organizations (ACOs), improve the quality and outcomes of health care for older adults with chronic illnesses.
The University of Michigan Cardiovascular Center is part of a national clinical trial to replace diseased valves with a minimally invasive procedure. It's a potentially transformative procedure for aortic stenosis patients who cannot tolerate open heart surgery.
Physicians at Rush University Medical Center are testing a unique gene therapy product called CERE-120 to evaluate if its use can improve the symptoms of Parkinson’s disease. Rush is one of 11 sites in the U.S. and the only site in Illinois enrolling patients into the new, double-blinded trial.
Dr. Mark Plunkett, the pediatric heart surgeon who helped establish the Kentucky Children’s Heart Center at the University of Kentucky in July of 2008, performed the 500th heart surgery on Feb. 15, 2011.
Surgeons at University of Utah Hospital have performed the hospital’s first implant of a new-generation left ventricular assist device (LVAD) using the HeartWare HVAD.
Vanderbilt-Ingram Cancer Center (VICC) has launched the nation’s first personalized cancer decision support tool, “My Cancer Genome,” to help physicians and researchers track the latest developments in personalized cancer medicine and connect with clinical research trials for their patients. This web-based information tool (www.MyCancerGenome.org) is designed to quickly educate clinicians on the rapidly expanding list of genetic mutations that impact different cancers and, at the same time, enable them to more easily research various treatment options based on specific mutations.
Two-thirds of people with diabetes have high blood pressure. Jenna L. Marquard of the University of Massachusetts Amherst is part of a research team developing a home blood pressure test for diabetics that sends the readings automatically to nurses so their medication can be adjusted as needed.
To better serve patients and the greater community, the Resource and Learning Center at New Jersey’s only NCI-Comprehensive Cancer Center is incorporating the Apple iPad and Barnes & Noble NOOK electronic reader into its information arsenal. As a result, traditional media focused on cancer-related topics can be accessed by users in a more portable fashion.
To help adult survivors of childhood cancer manage the unique long-term consequences of their treatment, Huntsman Cancer Institute (HCI) at the University of Utah has created the Pediatric Cancer Late Effects Clinic.
Researchers at the Cummings School of Veterinary Medicine have received U.S. patent approval for an antibody-based treatment for Hemolytic Uremic Syndrome (HUS), a potentially fatal outcome of E. coli poisoning and the leading cause of kidney failure in children.
A feasibility study to test the use of a scalp cooling device that breast cancer patients will wear while undergoing chemotherapy treatment will be conducted at Wake Forest University Baptist Medical Center.
Providing current and vital resources for implementation of health information technology to improve patient care, HIMSS continues to add new information to Meaningful Use OneSource, an online repository of hundreds of documents, tools and links to other knowledge available on the Internet. Users can go to www.himss.org/meaningfuluse to find this meaningful use compendium vetted by content experts before its inclusion on the website.
Researchers from the Georgia Institute of Technology have created a new sampling device that could prevent thousands of people worldwide from dying of pneumonia each year.
A special men’s health update from the Focused Ultrasound Surgery Foundation spotlights new minimally-invasive and highly precise treatments for prostate cancer and benign prostatic hyperplasia (BPH). The new treatments are expected to greatly reduce incontinence and impotence, which are common side effects associated with prostate procedures.
Nationwide Children’s Hospital has been selected to join the Autism Speaks Autism Treatment Network (ATN), connecting Columbus with Cincinnati Children’s Hospital Medical Center and the University of Missouri as the nation’s only ATN institutions in the Midwest region.
Mayo Clinic was awarded the Gold Seal of Approval for stroke care and re-accredited as an Advanced Primary Stroke Center by The Joint Commission (TJC) following an on-site review conducted Friday, Feb. 18.
Drug discovery drives a new collaboration between Saint Louis University's Center for World Health & Medicine and China's Guangzhou Institutes of Biomedicine and Health.
The American Medical Group Association announced today the release of a book on healthcare integration that provides guidance on how to lay the groundwork for a successful accountable care organization (ACO). Integrated Delivery Systems: A Cure for the Healthcare Delivery Crisis by Donn Sorensen and Amy Fore from St. John’s Health System, presents tools for developing integrated delivery systems (IDSs), which are the foundation of ACOs.
Provenge, the nation’s first FDA-approved cancer treatment vaccine, is now available at Roswell Park Cancer Institute (RPCI). RPCI is the first institution in Western New York to offer this vaccine, which is a treatment for advanced prostate cancer available to men who meet eligibility requirements.
Breast-cancer patient Kristin Wiginton is the first to be treated at UT Southwestern Medical Center with high-beam radiation using the Accuray CyberKnife System, which offers improved cosmetic results, less radiation exposure to surrounding tissue and a shorter treatment period.
Latinos are twice as likely to develop diabetes as Caucasians, and half the Latinos born in the United States in this century are predicted to get the disease. Helping to meet this challenge, Joslin Diabetes Center’s Latino Diabetes Initiative—a comprehensive effort that combines clinical care, patient education, community outreach, research and healthcare team education—has upgraded its website with additional resources for Latinos with diabetes and their families in both English and Spanish.
Research from The University of Texas Health Science Center at Houston (UTHealth) and Athersys reveals that a novel stem cell therapy provided multiple benefits when administered in preclinical models of ischemic stroke.
AUTM President Ashley Stevens, D. Phil. (Oxon), CLP is the lead author of The Role of Public Sector Research in the Discovery of Drugs and Vaccines, a paper published in the Feb. 10 issue of The New England Journal of Medicine.
BCIA has trademarked its logos and credentials in an effort to make a recogizable acronym for the delivery of clinical biofeedback services. This is a benefit for the consumer, health care and related industries, and all health care professionals.
Nearly $8 million of federal stimulus funds provided through the Ohio Health Information Partnership (OHIP) is already starting to help hundreds of doctors in northeast Ohio switch to electronic health records. Now, with a greater sense of urgency, the word is going out to providers who might not yet be aware that valuable advice is easily available to them.
The study will examine the patterns of fertility among women with epilepsy, compared to an age matched group of women without epilepsy. The research is being funded by the Milken Family Foundation.
The University of Texas MD Anderson Cancer Center's popular web-based teen prevention and smoking-cessation program, ASPIRE (A Smoking Prevention Interactive Experience), now speaks Spanish.
A new support service is being offered to personnel at Fort Hood in Texas. It is operated by the University Behavioral HealthCare unit of the University of Medicine and Dentistry of New Jersey, and patterned after a successful UMDNJ program that has served N.J. veterans for nearly six years.
Researchers at Memorial Sloan-Kettering Cancer Center’s Nanotechnology Center, along with collaborators at Cornell University and Hybrid Silica Technologies, have received approval for their first Investigational New Drug Application (IND) from the US Food and Drug Administration (FDA) for an ultrasmall silica inorganic nanoparticle platform for targeted molecular imaging of cancer, which may be useful for cancer treatment in the future.
“Cornell Dots” – brightly glowing nanoparticles – may soon be used to light up cancer cells to aid in diagnosing and treating cancer. The U.S. Food and Drug Administration (FDA) has approved the first clinical trial in humans of the new technology. It is the first time the FDA has approved using an inorganic material in the same fashion as a drug in humans.
Panera Bread® has expanded its contributions to the fight against cancer in the Garden State by selecting New Jersey’s only NCI-Comprehensive Cancer Center as its Community Breadbox Partner for 2011. Now through year’s end, funds collected through coin boxes near the registers at Panera Bread bakery-cafés in the central and northern regions of the state will benefit treatment, research, prevention and education efforts at The Cancer Institute of New Jersey.
The North Shore-LIJ Health System Department of Radiation Medicine announced today it is seeking patients with early-stage (confined to the organ) prostate cancer to participate in a Phase I Research study.
To meet the growing need for training and resources that respond to the nation’s aging population, University of the Sciences and Genesis HealthCare Corporation are launching The Genesis Healthcare Center for Aging Research and Education
Winter can be a tough time for seniors. Fauquier Health offers tips to help families identify when it might be time to transition a loved one into an assisted living facility.
Dr. Tanios Bekaii-Saab, medical director of gastrointestinal oncology at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James), is leading a new, two-arm, randomized phase II pancreatic cancer clinical trial that will study a formulation of the human reovirus that is designed to kill cancer cells.
Cancer Research Institute, a nonprofit organization, has awarded $450,000 to Oncovir, Inc., to Produce and Supply Hiltonol® (Poly-ICLC) for Use in Clinical Trials of Cancer Vaccines and Other Immunotherapies.
On Jan. 19, 2011, a free online counseling service will be available to expecting and breastfeeding moms anywhere in the country through the California Teratogen Information Service (CTIS).
Chances of becoming parents are constantly increasing with options that now include improved embryology laboratory techniques including day-5 blastocyst transfers, single embryo transfers, egg freezing, preimplantation genetic testing (PGD), and egg and sperm donation, all of which will be discussed Jan. 20 at Greenwich Hospital.
As the first major medical center in North Texas to implement electronic medical records in all its clinical practice groups, UT Southwestern Medical Center today applauded the government’s initiative to get hospitals and health care providers across the nation to embrace new health care technology.
Building upon recent laboratory discoveries on resistance by cancer cells to therapies that attempt to starve cancer, scientists at New Jersey’s only NCI Comprehensive Cancer Center are conducting a clinical trial that further explores how to prevent that action. The goal is to discover if an anti-malaria drug is able to block a cellular process that acts as a survival method for malignant cells in human melanoma.
The Mood Disorders Program at Case Western Reserve University School of Medicine and University Hospitals Case Medical Center, along with the Bipolar Trials Network, is launching Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness).
Residents of Cuyahoga County, and later Lorain County, will soon have the opportunity to contribute to the establishment of a national resource for childhood growth and development. The National Children’s Study is the largest, long-term study of children’s health ever conducted in the U.S.